Pathogenesis of the complement-mediated autoinflammatory disease atypical hemolytic uremic syndrome

Pathogenesis of the complement-mediated autoinflammatory disease atypical hemolytic uremic syndrome. Activating gain-of-function mutations in CFB increase C3bBb convertase stability and lead to permanent activation of the alternative pathway of complement. Autoantibodies against, and inactivating mutations within negative regulators of this process have also been described, such as for complement factor H (CFH) and membrane cofactor protein (MCP), which are cofactors for the inactivation of C3b by complement factor I (CFI). Asterisks denote proteins that carry mutations with known disease associations.
Pathogenesis of the complement-mediated autoinflammatory disease atypical hemolytic uremic syndrome

Publication

Horror Autoinflammaticus: The Molecular Pathophysiology of Autoinflammatory Disease. () Seth L. Masters, et al. Annu Rev Immunol. ;27:621-668. Figure: F5.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Homo sapiens Primates C5 C5 ncbigene_symbol C5 727
Homo sapiens Primates CFI CFI ncbigene_symbol CFI 3426
Homo sapiens Primates C3b C3B ncbigene_synonym C3 718
Homo sapiens Primates C3b C3B ncbigene_synonym ERVK-3 100862689
Homo sapiens Primates CFB CFB ncbigene_symbol CFB 629
Danio rerio Vertebrates C5 C5 ncbigene_symbol c5 565774
Danio rerio Vertebrates CFI CFI ncbigene_symbol cfi 557557
Danio rerio Vertebrates C3b C3B ncbigene_synonym c3a.2 30491
Danio rerio Vertebrates CFB CFB ncbigene_symbol cfb 30604

Chemical mentions

Word Match MeSH Name ChEBI

Disease mentions

Word Match MeSH Name DOID